Developer docs
API playgroundTry for free, no card

Search company profiles

SkinMed

Full company profile

uuid000t5ye

Namestring
SkinMed
Legal namestring
SkinMed Limited
Websiteurl
skinmed.co.uk
Company typeenum
Private
Founded yearint
2021
Descriptiontext

SkinMed Limited is a UK-based, privately held medical aesthetics company operating from Harrogate, North Yorkshire, that develops and distributes medically licensed dermatological protocols and products exclusively to medically-led aesthetic clinics across the United Kingdom. Its core technology stack is built around patented EnerPeel Carrier Technology (a delivery system for chemical peels), proprietary peptide and formulation chemistry including RO-peptide 23 (a direct KLK5/KLK7 inhibitor targeting cathelicidin processing in rosacea), Triethyl Citrate plus oligopeptide-10 acne formulations (Tebiskin OSK), Retimitate (a retinoic-acid equivalent without side effects), and microbiome-modulating seborrhoeic dermatitis products (Closebax). These components feed trademarked, multi-modal protocols such as the TripleLock Rosacea Protocol and Rosagate Transformation, each backed by clinical studies conducted in teaching hospitals across Italy, France, the Netherlands, Greece, Germany, and the UK.

The company's business model is a B2B direct-sales motion targeting doctor-, nurse-, and dermatologist-led clinics. Clinics purchase initial orders exceeding £500 (paid upfront before delivery), receive up to 80% discount on peels and 50%+ on Tebiskin products versus RRP, and resell treatments at retail. SkinMed monetizes across three streams: medical product sales, Level 5-7 CPD-accredited training via SkinMed Academy (£500 per session with £250 redeemable against opening orders), and trademarked protocol licensing (ARAUK accreditation pathway co-financed with the Acne and Rosacea Association UK). The company operates its own warehouse and distribution, and provides a managed marketing suite (bespoke landing pages, Meta advertising campaigns, email promotion, and creative assets) to drive patient footfall into partner clinics, targeting the 6.5 million UK women over 35 with maturity-onset acne or rosacea.

SkinMed monetizes its intellectual property and clinical evidence base through a high-touch partner ecosystem: 11-50 employees support a network of accredited clinics, with senior clinical authority anchored by Professor Tony Chu (President of ARAUK, 45+ years of dermatology experience). The company has no disclosed external funding, no subsidiaries, and no public market listing, and it has been actively extending its product surface in 2025 with Rosagate rosacea treatments, an acne in-clinic treatment plus overnight mask, and the consumer-facing SkinVital vitamin line, while maintaining strict medically-licensed product positioning.

Short descriptiontext

SkinMed Limited is a UK-based medical aesthetics company that develops medically licensed skin treatment protocols (Rosagate, Tebiskin OSK, Closebax, EnerPeel) and sells them exclusively to medically-led aesthetic clinics through direct B2B sales, supported by CPD-accredited training and managed marketing services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersScotton, United Kingdom
HQ citystring
Scotton
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical aesthetics products, clinical skin treatments, dermatology protocols, professional skincare training, clinic marketing services
Industry3 codes
PRIMARYCRABAAAK
Professional/Backbar Skincare (Esthetician & Spa Use)
SECONDARYHSALADAG
Chemical Peels (Light/Medium/Deep)
SECONDARYEDAOALAE
Esthetics / Skincare
Education/Vocational, Technical & Trade Education/Beauty, Cosmetology & Personal Care Training
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Medical Aesthetics Skincare
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Product Sales
TypeOne Time License
Description

SkinMed sells medically licensed skincare products and protocols to accredited aesthetic clinics. Products include Tebiskin range, EnerPeel peels, Rosagate professional and homecare products, and Closebax. Clinics purchase at significant discounts (up to 80% off RRP) and sell treatments at recommended retail prices.

skinmed.uk
2Professional Training Services
TypeProfessional Services
Description

Level 7 CPD-accredited training programmes delivered through SkinMed Academy. Training costs £500 ex VAT per session with £250 redeemable against opening orders. Includes ARAUK accreditation, scarring masterclass, and advanced skin science courses. Additional course modules available individually.

skinmed.uk
3Protocol Licensing
TypeLicensing Royalties
Description

SkinMed provides trademarked SkinMed Protocols to trained and accredited clinics, including the TripleLock Rosacea Protocol and acne treatment protocols. Clinics gain access to evidence-based clinical protocols developed by SkinMed.

skinmed.uk
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Marketing or Sales, Supply Chain, Operations, Technology or R&D, Others
Pricing details4 tiers
1Professional Training Session
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

£500 ex VAT per training session, redeemable £250 against opening order. Cancellation fee £250 plus VAT if cancelled within one week.

skinmed.uk
2Clinic Opening Order
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Initial order value should exceed £500. Introductory deals include Ultimate Plus packages with up to 50% free in products. Standard discount on peels: minimum 80% off RRP. Tebiskin range: 50% discount at RRP. Complete protocols average over 70% ROI for clinics.

skinmed.uk
3Derma FNS Device
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Derma FNS Pens available free when clinic buys three boxes of thirty needles beyond normal purchasing levels. Needle heads priced at £10 per unit (competitors charge up to £40).

skinmed.uk
4ARAUK Accreditation
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

Full course fee £300. SkinMed pays 50% contribution for clinics wishing to incorporate SkinMed protocols and achieve ARAUK accreditation.

skinmed.uk
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1SkinMed Academy
Description

CPD-accredited training platform offering Level 5 to 7 courses for healthcare professionals in acne, rosacea, and aesthetic treatments.

skinmed.uk
+6 more records
Core offering1 text field

SkinMed develops and supplies medically licensed skin treatment protocols, proprietary topical formulations, chemical peels, dermal needling devices, and clinically validated product ranges (Rosagate, Tebiskin OSK, Closebax, EnerPeel) exclusively to medically led aesthetic clinics in the UK. The company also operates the SkinMed Academy for CPD-accredited clinical training and a marketing suite that provides paid advertising, bespoke landing pages, and patient referral support to partner clinics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • Over 80% of resistant acne patients achieved clear or significantly improved skin within 3 months
+8 more records
Product overview1 text field

SkinMed is a medically-focused dermatology company offering a portfolio of clinically-proven, medically licensed skin solutions primarily for medically-led clinics. The core product ecosystem comprises: (1) Rosagate Protocol system - professional and home-use products for rosacea management with RO-peptide 23 as the key innovation; (2) Enerpeel chemical peel range with patented carrier technology for conditions including rosacea and acne; (3) Tebiskin OSK - non-antibiotic acne solution evolved from the original Aknicare formulation; (4) Closebax for seborrhoeic dermatitis; (5) Derma FNS automated dermal needling system; (6) SkinMed Academy - Level 7 CPD-accredited training platform covering acne, rosacea, scarring, and pigmentation; (7) SkinMed Marketing Suite - clinical marketing and client acquisition support; and (8) SkinVital consumer vitamins. The company operates a business-to-business model, selling exclusively to medically-led clinics and offering comprehensive marketing support to drive new client footfall, particularly targeting the 6.5 million UK women over 35 with maturity-onset acne or rosacea.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Professor Tony Chu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Professor Tony Chu serves as the lead instructor for SkinMed Academy's scarring masterclass and ARAUK accreditation programmes. He provides clinical expertise and educational content development. He also reviews difficult patients as a free diagnostic resource for clinics, contributing over 45 years of experience as lecturer, Professor, and President of the Acne and Rosacea Association UK.

skinmed.uk
2Acne and Rosacea Association UK (ARAUK)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SkinMed is a proud sponsor of ARAUK and finances online training for clinics so clinicians can become experts in treating acne and rosacea. The charity accreditation programme is delivered through SkinMed Academy with Professor Tony Chu as President. SkinMed also contributes 50% towards the £300 ARAUK accreditation course fee for partner clinics.

skinmed.uk
3Top Teaching Hospitals Across Europe
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Clinical trials conducted in medical research facilities and top teaching hospitals across Italy, France, The Netherlands, Greece, Germany, and the UK, involving trials published and conducted by top dermatology Professors.

skinmed.uk
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-headquartered professional skincare brand selling cosmeceutical formulations (vitamin C, retinoids, peels) through aesthetic clinics and dermatologists. Highly comparable B2B model targeting medically-led UK practices, with overlapping product categories (peels, vitamin A regimens) and a shared client base of clinic practitioners.

2SkinCeuticals
TypeBroad incumbent
Description

L'Oréal-owned medical-grade skincare brand offering vitamin C serums, corrective creams, and post-procedure regimens dispensed through physician offices and medical spas. Comparable medical-grade positioning and clinic channel, though broader portfolio and far greater scale.

TypeBroad incumbent
Description

Pharmaceutical-grade skincare company (now under Valeant/Bausch Health) selling tretinoin-based and hydroquinone systems through physicians for hyperpigmentation, acne, and anti-aging. Direct overlap on medically licensed prescription-strength positioning for chronic skin conditions.

TypeDirect peer
Description

Dr. Zein Obagi-founded professional skincare brand sold exclusively through physicians and medical spas, offering protocols for acne, pigmentation, and anti-aging. Closely comparable physician-channel distribution model and protocol-based treatment philosophy.

TypeDirect peer
Description

Professional chemical-peel and skincare brand sold through licensed skincare professionals and medical practices. Overlaps on professional peels, acne and rosacea protocols, and the medically-led clinic distribution model.

TypeDirect peer
Description

Medical-grade professional skincare brand sold exclusively through trained skin professionals, with a portfolio covering acne, rosacea, hyperpigmentation, and aging. Highly comparable B2B-only distribution, professional training requirement, and indication overlap with SkinMed.

TypeDirect peer
Description

Cosmeceutical brand offering clinical-grade skincare and post-procedure products distributed through medical spas, dermatologists, and plastic surgeons. Overlapping professional-channel distribution and clinical-trial-backed efficacy claims.

8Aesthetic Source
TypeRegional player
Description

UK-exclusive distributor of professional skincare and aesthetic brands (e.g., SkinCeuticals, Obagi, iS Clinical, SkinTech) to medical aesthetic clinics. Comparable UK channel partner for medically-led practices, though as a multi-brand distributor rather than a proprietary brand.

TypeRegional player
Description

UK-specialist pharmacy and distributor of aesthetic medical products, devices, and pharmaceuticals to clinics. Comparable UK-only channel reach into aesthetic practices and overlapping clinic-customer base, though focused on distribution rather than proprietary protocols.

10Skinbetter Science
TypeEmerging player
Description

Physician-dispensed skincare line developed by industry veterans, sold exclusively through authorized medical providers with patented delivery technologies — directly mirrors SkinMed's approach of combining proprietary chemistry with physician-only distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SkinMed

Medical Aesthetics Skincareskinmed.co.uk

SkinMed Limited is a UK-based medical aesthetics company that develops medically licensed skin treatment protocols (Rosagate, Tebiskin OSK, Closebax, EnerPeel) and sells them exclusively to medically-led aesthetic clinics through direct B2B sales, supported by CPD-accredited training and managed marketing services.

What SkinMed does

SkinMed Limited is a UK-based, privately held medical aesthetics company operating from Harrogate, North Yorkshire, that develops and distributes medically licensed dermatological protocols and products exclusively to medically-led aesthetic clinics across the United Kingdom. Its core technology stack is built around patented EnerPeel Carrier Technology (a delivery system for chemical peels), proprietary peptide and formulation chemistry including RO-peptide 23 (a direct KLK5/KLK7 inhibitor targeting cathelicidin processing in rosacea), Triethyl Citrate plus oligopeptide-10 acne formulations (Tebiskin OSK), Retimitate (a retinoic-acid equivalent without side effects), and microbiome-modulating seborrhoeic dermatitis products (Closebax). These components feed trademarked, multi-modal protocols such as the TripleLock Rosacea Protocol and Rosagate Transformation, each backed by clinical studies conducted in teaching hospitals across Italy, France, the Netherlands, Greece, Germany, and the UK.

The company's business model is a B2B direct-sales motion targeting doctor-, nurse-, and dermatologist-led clinics. Clinics purchase initial orders exceeding £500 (paid upfront before delivery), receive up to 80% discount on peels and 50%+ on Tebiskin products versus RRP, and resell treatments at retail. SkinMed monetizes across three streams: medical product sales, Level 5-7 CPD-accredited training via SkinMed Academy (£500 per session with £250 redeemable against opening orders), and trademarked protocol licensing (ARAUK accreditation pathway co-financed with the Acne and Rosacea Association UK). The company operates its own warehouse and distribution, and provides a managed marketing suite (bespoke landing pages, Meta advertising campaigns, email promotion, and creative assets) to drive patient footfall into partner clinics, targeting the 6.5 million UK women over 35 with maturity-onset acne or rosacea.

SkinMed monetizes its intellectual property and clinical evidence base through a high-touch partner ecosystem: 11-50 employees support a network of accredited clinics, with senior clinical authority anchored by Professor Tony Chu (President of ARAUK, 45+ years of dermatology experience). The company has no disclosed external funding, no subsidiaries, and no public market listing, and it has been actively extending its product surface in 2025 with Rosagate rosacea treatments, an acne in-clinic treatment plus overnight mask, and the consumer-facing SkinVital vitamin line, while maintaining strict medically-licensed product positioning.

SkinMed firmographics

Firmographics
Name
SkinMed
Legal name
SkinMed Limited
Website
https://skinmed.co.uk
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
SkinMed Limited is a UK-based medical aesthetics company that develops medically licensed skin treatment protocols (Rosagate, Tebiskin OSK, Closebax, EnerPeel) and sells them exclusively to medically-led aesthetic clinics through direct B2B sales, supported by CPD-accredited training and managed marketing services.
Ownership category
akta.pro rank

SkinMed industry classification

Industry
Product category
Medical Aesthetics Skincare
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro industry
PRIMARYCRABAAAK
Professional/Backbar Skincare (Esthetician & Spa Use)
SECONDARYHSALADAG
Chemical Peels (Light/Medium/Deep)
SECONDARYEDAOALAE
Esthetics / Skincare
Education/Vocational, Technical & Trade Education/Beauty, Cosmetology & Personal Care Training

Keywords

  • Medical aesthetics products
  • Clinical skin treatments
  • Dermatology protocols
  • Professional skincare training
  • Clinic marketing services

Where SkinMed is headquartered

Location

Headquarters

HQ city
Scotton
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

SkinMed business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Marketing or Sales, Supply Chain, Operations, Technology or R&D, Others

Revenue model

  1. Medical Product Sales: SkinMed sells medically licensed skincare products and protocols to accredited aesthetic clinics. Products include Tebiskin range, EnerPeel peels, Rosagate professional and homecare products, and Closebax. Clinics purchase at significant discounts (up to 80% off RRP) and sell treatments at recommended retail prices.
  2. Professional Training Services: Level 7 CPD-accredited training programmes delivered through SkinMed Academy. Training costs £500 ex VAT per session with £250 redeemable against opening orders. Includes ARAUK accreditation, scarring masterclass, and advanced skin science courses. Additional course modules available individually.
  3. Protocol Licensing: SkinMed provides trademarked SkinMed Protocols to trained and accredited clinics, including the TripleLock Rosacea Protocol and acne treatment protocols. Clinics gain access to evidence-based clinical protocols developed by SkinMed.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseOne time/ perpetual licenseProfessional Training Session
Unit PricingPay-as-you-goClinic Opening Order
Unit PricingPay-as-you-goDerma FNS Device
One time/ perpetual licenseOne time/ perpetual licenseARAUK Accreditation

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

SkinMed product offering

Product offering

Core offering

SkinMed develops and supplies medically licensed skin treatment protocols, proprietary topical formulations, chemical peels, dermal needling devices, and clinically validated product ranges (Rosagate, Tebiskin OSK, Closebax, EnerPeel) exclusively to medically led aesthetic clinics in the UK. The company also operates the SkinMed Academy for CPD-accredited clinical training and a marketing suite that provides paid advertising, bespoke landing pages, and patient referral support to partner clinics.

Product overview

SkinMed is a medically-focused dermatology company offering a portfolio of clinically-proven, medically licensed skin solutions primarily for medically-led clinics. The core product ecosystem comprises: (1) Rosagate Protocol system - professional and home-use products for rosacea management with RO-peptide 23 as the key innovation; (2) Enerpeel chemical peel range with patented carrier technology for conditions including rosacea and acne; (3) Tebiskin OSK - non-antibiotic acne solution evolved from the original Aknicare formulation; (4) Closebax for seborrhoeic dermatitis; (5) Derma FNS automated dermal needling system; (6) SkinMed Academy - Level 7 CPD-accredited training platform covering acne, rosacea, scarring, and pigmentation; (7) SkinMed Marketing Suite - clinical marketing and client acquisition support; and (8) SkinVital consumer vitamins. The company operates a business-to-business model, selling exclusively to medically-led clinics and offering comprehensive marketing support to drive new client footfall, particularly targeting the 6.5 million UK women over 35 with maturity-onset acne or rosacea.

Differentiator

Problem solved

Functional benefit

Brands

  • SkinMed Academy: CPD-accredited training platform offering Level 5 to 7 courses for healthcare professionals in acne, rosacea, and aesthetic treatments.
  • ARAUK (Acne and Rosacea Association UK)
  • Rosagate
  • TripleLock® Rosacea Protocol
  • Tebiskin OSK
  • EnerPeel
  • Closebax

Quantifiable outcome

  • Over 80% of resistant acne patients achieved clear or significantly improved skin within 3 months
  • +8 more outcomes

Companies that use SkinMed

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles2 records

SkinMed technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

SkinMed partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Professor Tony ChucoreStrategic or Co-development PartnerProfessor Tony Chu serves as the lead instructor for SkinMed Academy's scarring masterclass and ARAUK accreditation programmes. He provides clinical expertise and educational content development. He also reviews difficult patients as a free diagnostic resource for clinics, contributing over 45 years of experience as lecturer, Professor, and President of the Acne and Rosacea Association UK.
  • Acne and Rosacea Association UK (ARAUK)coreStrategic or Co-development PartnerSkinMed is a proud sponsor of ARAUK and finances online training for clinics so clinicians can become experts in treating acne and rosacea. The charity accreditation programme is delivered through SkinMed Academy with Professor Tony Chu as President. SkinMed also contributes 50% towards the £300 ARAUK accreditation course fee for partner clinics.
  • Top Teaching Hospitals Across EuropeminorImplementation/ SI/ Consulting PartnerClinical trials conducted in medical research facilities and top teaching hospitals across Italy, France, The Netherlands, Greece, Germany, and the UK, involving trials published and conducted by top dermatology Professors.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

SkinMed competitors and assessment

Company assessment

Direct peers

  • Medik8: UK-headquartered professional skincare brand selling cosmeceutical formulations (vitamin C, retinoids, peels) through aesthetic clinics and dermatologists. Highly comparable B2B model targeting medically-led UK practices, with overlapping product categories (peels, vitamin A regimens) and a shared client base of clinic practitioners.
  • ZO Skin Health: Dr. Zein Obagi-founded professional skincare brand sold exclusively through physicians and medical spas, offering protocols for acne, pigmentation, and anti-aging. Closely comparable physician-channel distribution model and protocol-based treatment philosophy.
  • PCA Skin: Professional chemical-peel and skincare brand sold through licensed skincare professionals and medical practices. Overlaps on professional peels, acne and rosacea protocols, and the medically-led clinic distribution model.
  • Alumier MD: Medical-grade professional skincare brand sold exclusively through trained skin professionals, with a portfolio covering acne, rosacea, hyperpigmentation, and aging. Highly comparable B2B-only distribution, professional training requirement, and indication overlap with SkinMed.
  • iS Clinical: Cosmeceutical brand offering clinical-grade skincare and post-procedure products distributed through medical spas, dermatologists, and plastic surgeons. Overlapping professional-channel distribution and clinical-trial-backed efficacy claims.

Broad incumbents

  • SkinCeuticals: L'Oréal-owned medical-grade skincare brand offering vitamin C serums, corrective creams, and post-procedure regimens dispensed through physician offices and medical spas. Comparable medical-grade positioning and clinic channel, though broader portfolio and far greater scale.
  • Obagi Medical: Pharmaceutical-grade skincare company (now under Valeant/Bausch Health) selling tretinoin-based and hydroquinone systems through physicians for hyperpigmentation, acne, and anti-aging. Direct overlap on medically licensed prescription-strength positioning for chronic skin conditions.

Regional players

  • Aesthetic Source: UK-exclusive distributor of professional skincare and aesthetic brands (e.g., SkinCeuticals, Obagi, iS Clinical, SkinTech) to medical aesthetic clinics. Comparable UK channel partner for medically-led practices, though as a multi-brand distributor rather than a proprietary brand.
  • Healthxchange Group: UK-specialist pharmacy and distributor of aesthetic medical products, devices, and pharmaceuticals to clinics. Comparable UK-only channel reach into aesthetic practices and overlapping clinic-customer base, though focused on distribution rather than proprietary protocols.

Emerging players

  • Skinbetter Science: Physician-dispensed skincare line developed by industry veterans, sold exclusively through authorized medical providers with patented delivery technologies — directly mirrors SkinMed's approach of combining proprietary chemistry with physician-only distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

SkinMed social profiles

Digital presence

SkinMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SkinMed leadership team

Management profile

Number of profiles

SkinMed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SkinMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SkinMed

What does SkinMed do?

SkinMed develops and supplies medically licensed skin treatment protocols, proprietary topical formulations, chemical peels, dermal needling devices, and clinically validated product ranges (Rosagate, Tebiskin OSK, Closebax, EnerPeel) exclusively to medically led aesthetic clinics in the UK. The company also operates the SkinMed Academy for CPD-accredited clinical training and a marketing suite that provides paid advertising, bespoke landing pages, and patient referral support to partner clinics.

Is SkinMed a public or private company?

SkinMed is a private company. It is classified as unknown and is currently operating.

When was SkinMed founded?

SkinMed was founded in 2021. It employs 1 to 10 people.

Where is SkinMed based?

SkinMed is headquartered in Scotton, United Kingdom, in the Europe region.

How does SkinMed make money?

Three revenue lines are on record. Medical Product Sales are the primary driver. The others are professional Training Services and protocol Licensing.

Who are SkinMed's main competitors?

Direct peers on record are Medik8, ZO Skin Health, PCA Skin, Alumier MD and iS Clinical. Broad incumbents are SkinCeuticals and Obagi Medical. Regional players are Aesthetic Source and Healthxchange Group. Skinbetter Science is listed as an emerging player.

Does SkinMed have an API?

No public API is recorded for SkinMed.

What industry is SkinMed in?

SkinMed's product category is Medical Aesthetics Skincare. Its primary akta.pro industry code is CRABAAAK, Professional/Backbar Skincare (Esthetician & Spa Use), with a secondary code of HSALADAG, Chemical Peels (Light/Medium/Deep). Its NAICS code is 325412 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales